A detailed history of Caxton Associates LP transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Caxton Associates LP holds 20,762 shares of CPRX stock, worth $448,459. This represents 0.02% of its overall portfolio holdings.

Number of Shares
20,762
Holding current value
$448,459
% of portfolio
0.02%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.19 - $21.35 $315,374 - $443,268
20,762 New
20,762 $412,000
Q2 2022

Aug 15, 2022

SELL
$6.23 - $8.57 $574,804 - $790,702
-92,264 Reduced 74.05%
32,338 $227,000
Q1 2022

May 16, 2022

BUY
$5.31 - $8.31 $445,997 - $697,973
83,992 Added 206.83%
124,602 $1.03 Million
Q3 2021

Nov 15, 2021

SELL
$4.85 - $6.04 $11,703 - $14,574
-2,413 Reduced 5.61%
40,610 $215,000
Q2 2021

Aug 16, 2021

BUY
$4.29 - $6.05 $79,068 - $111,507
18,431 Added 74.95%
43,023 $247,000
Q4 2020

Feb 16, 2021

BUY
$2.97 - $3.83 $38,725 - $49,939
13,039 Added 112.86%
24,592 $82,000
Q3 2020

Nov 16, 2020

SELL
$2.97 - $5.08 $279,622 - $478,276
-94,149 Reduced 89.07%
11,553 $34,000
Q2 2020

Aug 14, 2020

BUY
$3.48 - $5.05 $277,084 - $402,091
79,622 Added 305.3%
105,702 $488,000
Q1 2020

May 15, 2020

BUY
$2.61 - $5.21 $68,068 - $135,876
26,080 New
26,080 $100,000

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.22B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.